The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Feb. 14, 2023

Filed:

Dec. 12, 2017
Applicants:

The Broad Institute, Inc., Cambridge, MA (US);

Massachusetts Institute of Technology, Cambridge, MA (US);

President and Fellows of Harvard College, Cambridge, MA (US);

University of Tokyo, Tokyo, JP;

Inventors:

Feng Zhang, Cambridge, MA (US);

Winston Yan, Brookline, MA (US);

Osamu Nureki, Yokohama, JP;

Kaijie Zheng, San Francisco, CA (US);

Le Cong, Cambridge, MA (US);

Hiroshi Nishimasu, Tokyo, JP;

Fei Ran, Boston, MA (US);

Yinqing Li, Cambridge, MA (US);

Assignees:
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
C12N 9/22 (2006.01); G16B 15/00 (2019.01); C12N 15/10 (2006.01); G16B 15/30 (2019.01); G16B 15/20 (2019.01); C12N 15/11 (2006.01);
U.S. Cl.
CPC ...
C12N 9/22 (2013.01); C12N 15/102 (2013.01); C12N 15/11 (2013.01); G16B 15/00 (2019.02); G16B 15/20 (2019.02); G16B 15/30 (2019.02); C07K 2299/00 (2013.01); C07K 2319/09 (2013.01); C07K 2319/095 (2013.01); C07K 2319/20 (2013.01); C07K 2319/70 (2013.01); C12N 2310/20 (2017.05); C12N 2800/80 (2013.01);
Abstract

The invention provides for systems, methods, and compositions for altering expression of target gene sequences and related gene products. Provided are structural information on the Cas protein of the CRISPR-Cas system, use of this information in generating modified components of the CRISPR complex, vectors and vector systems which encode one or more components or modified components of a CRISPR complex, as well as methods for the design and use of such vectors and components. Also provided are methods of directing CRISPR complex formation in eukaryotic cells and methods for utilizing the CRISPR-Cas system. In particular the present invention comprehends optimized functional CRISPR-Cas enzyme systems. In particular the present invention comprehends engineered new guide architectures and enzymes to be used in optimizedCRISPR-Cas enzyme systems.


Find Patent Forward Citations

Loading…